TipRanks
Vaccinex Inc (VCNX)
OTHER OTC:VCNX
US Market
VCNX
Vaccinex
RESEARCH TOOLSreports
Want to see VCNX full AI Analyst Report?

Vaccinex (VCNX) Ratios

304 Followers

Vaccinex Ratios

VCNX's free cash flow for Q4 2024 was $1.00. For the 2024 fiscal year, VCNX's free cash flow was decreased by $ and operating cash flow was $-15.83. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.45 0.45 0.50 0.57 2.95
Quick Ratio
 0.45 0.45 0.50 0.57 2.95
Cash Ratio
 0.04 0.04 0.22 0.26 2.52
Solvency Ratio
 -0.56 -0.56 -3.65 -3.39 -7.01
Operating Cash Flow Ratio
 -1.67 -1.67 -3.18 -2.91 -7.52
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -647.44 -229.79 -257.76
Net Current Asset Value
$ -7.63M$ -7.63M$ -2.55M$ -2.59M$ 4.69M
Leverage Ratios
Debt-to-Assets Ratio
 3.07 3.07 <0.01 0.07 0.06
Debt-to-Equity Ratio
 -0.73 -0.73 -0.01 -0.11 0.09
Debt-to-Capital Ratio
 -2.66 -2.66 -0.01 -0.12 0.09
Long-Term Debt-to-Capital Ratio
 -2.66 -2.66 0.00 -0.01 0.02
Financial Leverage Ratio
 -0.24 -0.24 -1.04 -1.57 1.54
Debt Service Coverage Ratio
 -39.37 -39.37 -686.59 -259.84 -257.97
Interest Coverage Ratio
 -39.64 -39.64 -9.37K -22.89K -9.95K
Debt to Market Cap
 2.06 1.91 0.01 0.02 <0.01
Interest Debt Per Share
 2.11 2.11 0.01 0.53 2.41
Net Debt to EBITDA
 -1.03 -1.03 0.06 0.07 0.30
Profitability Margins
Gross Profit Margin
98.33%98.33%100.00%100.00%68.00%
EBIT Margin
-249.74%-249.74%-3100.17%-3485.44%-19813.00%
EBITDA Margin
-248.07%-248.07%-3084.53%-3464.56%-19606.00%
Operating Profit Margin
-249.74%-249.74%-3117.30%-4014.91%-19906.00%
Pretax Profit Margin
-251.07%-251.07%-3100.50%-3552.81%-19815.00%
Net Profit Margin
-251.07%-251.07%-3100.50%-3552.81%-19722.00%
Continuous Operations Profit Margin
-251.07%-251.07%-3100.50%-3552.81%-19815.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%99.53%
EBT Per EBIT
100.54%100.54%99.46%88.49%99.54%
Return on Assets (ROA)
-292.38%-292.38%-717.80%-557.73%-247.24%
Return on Equity (ROE)
104.38%69.29%748.95%876.29%-379.78%
Return on Capital Employed (ROCE)
252.27%252.27%753.01%1001.53%-365.92%
Return on Invested Capital (ROIC)
252.27%252.27%760.66%1108.77%-350.58%
Return on Tangible Assets
-292.38%-292.38%-717.80%-557.73%-247.24%
Earnings Yield
-196.52%-181.96%-905.90%-472.70%-72.61%
Efficiency Ratios
Receivables Turnover
 1.81 1.81 0.72 0.59 0.57
Payables Turnover
 0.01 0.01 0.00 0.00 0.14
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 53.72 53.72 9.25 2.02 0.20
Asset Turnover
 1.16 1.16 0.23 0.16 0.01
Working Capital Turnover Ratio
 -0.90 -0.90 -0.23 0.48 0.02
Cash Conversion Cycle
 -35.97K -35.97K 508.94 615.38 -2.04K
Days of Sales Outstanding
 201.23 201.23 508.94 615.38 638.75
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 36.17K 36.17K 0.00 0.00 2.68K
Operating Cycle
 201.23 201.23 508.94 615.38 638.75
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.41 -2.41 -7.71 -37.17 -94.39
Free Cash Flow Per Share
 -2.41 -2.41 -7.72 -37.31 -94.88
CapEx Per Share
 <0.01 <0.01 0.01 0.14 0.49
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -716.67 -716.67 -735.73 -257.22 -192.67
Capital Expenditure Coverage Ratio
 -716.67 -716.67 -735.73 -257.22 -192.67
Operating Cash Flow Coverage Ratio
 -1.17 -1.17 -647.44 -69.77 -39.33
Operating Cash Flow to Sales Ratio
 -3.08 -3.08 -26.93 -30.24 -190.74
Free Cash Flow Yield
-241.31%-223.44%-787.96%-403.84%-70.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.51 -0.55 -0.11 -0.21 -1.38
Price-to-Sales (P/S) Ratio
 1.28 1.38 3.42 7.52 271.60
Price-to-Book (P/B) Ratio
 -0.35 -0.38 -0.83 -1.85 5.23
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.41 -0.45 -0.13 -0.25 -1.42
Price-to-Operating Cash Flow Ratio
 -0.41 -0.45 -0.13 -0.25 -1.42
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 0.03
Price-to-Fair Value
 -0.35 -0.38 -0.83 -1.85 5.23
Enterprise Value Multiple
 -1.55 -1.59 -0.05 -0.15 -1.08
Enterprise Value
 8.05M 8.27M 974.97K 3.00M 21.25M
EV to EBITDA
 -1.55 -1.59 -0.05 -0.15 -1.08
EV to Sales
 3.84 3.95 1.62 5.26 212.54
EV to Free Cash Flow
 -1.25 -1.28 -0.06 -0.17 -1.11
EV to Operating Cash Flow
 -1.25 -1.28 -0.06 -0.17 -1.11
Tangible Book Value Per Share
 -2.84 -2.84 -1.19 -4.98 25.70
Shareholders’ Equity Per Share
 -2.84 -2.84 -1.19 -4.98 25.70
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.78 0.78 0.29 1.23 0.49
Net Income Per Share
 -1.97 -1.97 -8.88 -43.68 -97.59
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.01 1.01 1.00 1.02 1.00
Research & Development to Revenue
 2.01 2.01 20.87 29.08 139.79
SG&A to Revenue
 1.47 1.47 11.30 12.07 62.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.57 0.83 5.45
Income Quality
 1.23 1.23 0.87 0.85 0.96
Currency in USD